HUM vs PALI · P/E 39, rev $117.76B vs P/E 15, $316.3M cap
Humana Inc (HUM) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PALI revenue for 2024-12-31 was $0. Net income was -$14.4M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the HUM and PALI stock pages for the full models.
Not investment advice.